Skip to main content
Adrian Vella, MD, Endocrinology, Rochester, MN

Adrian Vella MD

Endocrinology•Rochester, MN

Diabetes, Lipid Metabolism

Professor, Internal Medicine, Mayo Medical School

Join to view full profile

  • 200 1st St SwRochester, MN 55905

  • Phone+1 507-284-2511

Dr. Vella is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Vella's full profileAlready have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1995 - 1998
  • University of Malta School of Medicine
    University of Malta School of MedicineClass of 1993
  • University of Malta
    University of MaltaBasic Medical Science Training, With Distinction, 1988 - 1990
  • GF Abela Lyceum
    GF Abela LyceumA-Level Studies, Physics, Chemistry, Biology, Philosophy & Computer Science, 1986 - 1988

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1997 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
  • CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017
  • CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies  
    Tracey McLaughlin, Adrian Vella, The Journal of Clinical Endocrinology and Metabolism
  • The Oral Minimal Model Method  
    Cobelli C, Dalla Man C, Toffolo G, Basu R, Vella A, Rizza R, Diabetes, 4/1/2014
  • Beta-Cell Function After Weight-Loss Induced by Bariatric Surgery  
    Vella A., Physiology (Bethesda), 3/1/2014

Books/Book Chapters

  • Companion to Peripheral Neuropathy: Illustrated Cases And New Developments 
    Chapter: Evaluation of diabetic polyneuropathy: design of the neurologic examination versus clinical neurophysiology tests trial. 
    Page 321 - 326Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, O'Brien PC, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW...Editors: Dyck PJ; et al.Saunders/Elsevier, Philadelphia2010
  • Companion to Peripheral Neuropathy: Illustrated Cases And New Developments 
    Chapter: Testing of touch-pressure sensation: introduction of the touch-pressure sensogram. 
    Page 327 - 329Dyck PJ, Winkler JA, Andrews KL, Kavros SJ, Vella A, Davies JLEditors: Dyck PJ; et al.Saunders/Elsevier, Philadelphia2010
  • Pharmacology And Therapeutics: Principles To Practice 
    Chapter: Diabetes mellitus. 
    Page 557 - 570Rizza RA, Vella AEditors: Waldman SA, Terzic A.Saunders/Elsevier, Philadelphia2009

Abstracts/Posters

  • Diabetes-associated genetic variation and GLP-1 secretion and action GLP-1 in non-diabetic subjects.
    Smushkin G, Dalla Man C, Micheletto F, Sathananthan A, Camilleri M, Cobelli C, Rizza RA, Vella A, Diabetes and Prediabetes, Madrid, 4/1/2011
  • Minimal Model indices and genetic biomarkers in the pathogenesis of diabetes.
    Sambo F, Di Camillo B, Toffolo G, Dalla Man C, Cobelli C, Vella A, Diabetes and Prediabetes, Madrid, 4/1/2011
  • The interaction of colesevelam with sitagliptin suggests differential effects on fasting and postprandial glucose metabolism in subjects with type 2 diabetes.
    Smushkin G, Dalla Man C, Sathananthan M, Cobelli C, Vella A, EASD, 1/1/2011

Lectures

  • Clinical Aspects of Glycemic Control: From Hypoglycemia to Novel Therapeutic Pathways 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Effects of Metformin on Bile Acid Metabolism in Type 2 Diabetes 
    Rochester, MN - 6/15/2014

Press Mentions

  • Mayo Clinic Study Indicates Rural US Counties Have Higher Diabetes-Related Deaths
    Mayo Clinic Study Indicates Rural US Counties Have Higher Diabetes-Related DeathsSeptember 29th, 2022
  • The #1 Cause of Diabetes, According to Physicians
    The #1 Cause of Diabetes, According to PhysiciansJuly 6th, 2022
  • Children Are up to 2.5 Times More Likely to Develop Diabetes After COVID-19 Infection, Study Finds
    Children Are up to 2.5 Times More Likely to Develop Diabetes After COVID-19 Infection, Study FindsJanuary 11th, 2022

Grant Support

  • The effect of endogenous GLP-1 secretion on islet function in vivoMAYO CLINIC ROCHESTER2020–2030
  • The regulation of fasting glucose metabolism in people with and without prediabetesMAYO CLINIC ROCHESTER2007–2029
  • Glucagon secretion and action in humansMAYO CLINIC ROCHESTER2017–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Adrian Vella, Dr. Adrian Vella, MD, Dr. A Vella